G3171
Glycinin from Glycine max (soybean)
soybean storage protein
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352202
Form:
lyophilized powder
Assay:
≥80% (HPLC)
Biological source:
Glycine max (soybean)
biological source
Glycine max (soybean)
assay
≥80% (HPLC)
form
lyophilized powder
storage temp.
−20°C
Gene Information
soybean ... GY1(547901), GY2(547900), GY3(547463), GY4(100101841), GY5(547452)
General description
Glycinins are a family of soybean storage proteins produced during embryogenesis. Glycinin is a major allergen within soy and is a soluble glycoprotein that exists in a homo-hexameric form. At least five genes encode for the most abundant subunits.
Naturally occuring mixture of glycinin isoforms
Biochem/physiol Actions
Glycinin is a hexameric protein containing six similar subunits, each of which comprises an acidic polypeptide chain connected by disulfide bonds to a basic polypeptide chain.
signalword
Danger
hcodes
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Guanhao Bu et al.
Journal of the science of food and agriculture, 97(7), 2256-2262 (2016-10-19)
Soybean glycinin is considered a major allergenic protein, and glycation is widely used to reduce the allergenic potential of present allergens. Glycation of soybean glycinin with xylose at 55 °C for different lengths of time was investigated. The extent of Maillard
H Narchi et al.
Journal of pediatric surgery, 23(9), 839-841 (1988-09-01)
Six children with shunt nephritis are reported of whom two did not show complete recovery of renal function. Follow up and outcome in relation to the delay in diagnosis and renal biopsy appearances are discussed.
Dario Balestra et al.
International journal of molecular sciences, 20(17) (2019-08-28)
Mutations in the CDKL5 gene lead to an incurable rare neurological condition characterized by the onset of seizures in the first weeks of life and severe intellectual disability. Replacement gene or protein therapies could represent intriguing options, however, their application
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service